<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<base href="SHH%206/9/25%201R">
<title>S4030 1R</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:AlbertusExtraBold;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US style='word-wrap:break-word'>

<div class=WordSection1>

<p class=bpuReprint><a name=bpuFrontPg></a>[First Reprint]</p>

<p class=bpuBill>SENATE, No. 4030 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED JANUARY 14, 2025</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  VIN GOPAL</p>

<p class=bpuSponsor>District 11 (Monmouth)</p>

<p class=bpuSponsor>Senator  TROY SINGLETON</p>

<p class=bpuSponsor>District 7 (Burlington)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Senators Diegnan, Amato, McKnight, Greenstein and Zwicker</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Requires health care professionals to report cases of
amyotrophic lateral sclerosis and motor neuron disease.</p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As reported by the Senate Health, Human Services and
Senior Citizens Committee on June 9, 2025, with amendments.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
150%'><b><span style='line-height:150%;font-variant:small-caps;letter-spacing:
0pt'>An Act</span></b> concerning amyotrophic lateral sclerosis <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u><span
style='letter-spacing:0pt'>and motor neuron disease</span></u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> and
supplementing Title 26 of the Revised Statutes.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      1. 
a.  As used in this section:</span></p>

<p class=MsoNormal style='line-height:150%'><b><sup><span style='letter-spacing:
0pt'>        </span></sup></b><span style='letter-spacing:0pt'>Amyotrophic
lateral sclerosis means a progressive neurodegenerative disease that affects
nerve cells in the brain and the spinal cord.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      &quot;Health
care professional&quot; means a person licensed to practice a health care
profession pursuant to Title 45 of the Revised Statutes.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u><span
style='letter-spacing:0pt'>&quot;Motor neuron disease&quot; means a group of
progressive neurological conditions that destroy motor neurons, which are the
cells that control skeletal muscle activity such as walking, breathing,
speaking, and swallowing; and include amyotrophic lateral sclerosis,
progressive bulbar palsy, primary lateral sclerosis, progressive muscular
atrophy, spinal muscular atrophy, Kennedys disease, and post-polio syndrome.</span></u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b. 
(1) Consistent with federal and State privacy laws, the Department of Health
shall require health care professionals, who screen for, diagnose, or provide
therapeutic services to patients with amyotrophic lateral sclerosis </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u><span
style='letter-spacing:0pt'>or motor neuron disease</span></u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'>, to confidentially report to the</span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'> department</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>New Jersey State Health Assessment Data System</u></span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'> all known cases of amyotrophic lateral sclerosis </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u><span
style='letter-spacing:0pt'>and motor neuron disease</span></u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'> in a manner to be specified by the department </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u><span
style='letter-spacing:0pt'>no later than six months following a patients
amyotrophic lateral sclerosis or motor neuron disease diagnosis</span></u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'>.  </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)
Any information reported to the </span><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>department</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>New Jersey State Health Assessment Data System</u></span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'> pursuant to this subsection shall be reported in a
manner to protect against the disclosure of any confidential or personal
identifying information of any patient or health care professional. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)
The </span><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>Commissioner of Health may enter into data sharing
and protection agreements with researchers or State, regional, or national
amyotrophic lateral sclerosis registries for bidirectional data exchange for
research purposes, provided that access to data under the agreements is
consistent with the privacy, security, and disclosure protections under this
act.  In the case of researchers, the commissioner shall first obtain evidence
of the approval of the researchers academic committee for the protection of human
subjects established in accordance with the provisions of 45 C.F.R. Part 46. 
The commissioner shall disclose the minimum amount of information necessary to
accomplish a specified research purpose</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>department may enter into agreements to provide
the data reported to the New Jersey State Health Assessment Data System
pursuant to this subsection with the federal Centers for Disease Control and
Prevention and any other successor agency, local health officers, or
researchers of the study of amyotrophic lateral sclerosis or motor neuron
disease for public health and research purposes.  Any data provided to the
federal Centers for Disease Control and Prevention and any other successor
agency, local health officers, or researchers of the study of amyotrophic lateral
sclerosis or motor neuron disease pursuant to this paragraph shall be reported
in a manner to protect against the disclosure of any confidential or personal
identifying information of any patient or health care professional</u></span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'>.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      c. 
The </span><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>department</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>New Jersey State Health Assessment Data System</u></span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'> shall record and compile information received
pursuant to this section for research and statistical purposes only.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      d. 
Nothing in this act shall be construed to authorize the disclosure of any
confidential or personal identifying information.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      e. 
No later than 12 months following the effective date of this act, the
Commissioner of Health shall develop and make available on its Internet website
written, educational materials that provide information about the </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>National Amyotrophic Lateral Sclerosis Registry</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>New Jersey State Health Assessment Data System</u></span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'>, including:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>(1) information on how to participate in the
National Amyotrophic Lateral Sclerosis Registry and resources for assistance
with the registration process;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)
information regarding the eligibility requirements for participation in the
National Amyotrophic Lateral Sclerosis Registry; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)
contact information for the National Amyotrophic Lateral Sclerosis Registry and
for local and national research entities investigating the causes of
amyotrophic lateral sclerosis</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>information on how to access the datasets,
statistics, and information regarding amyotrophic lateral sclerosis and motor
neuron disease reported to the New Jersey State Health Assessment Data System
pursuant to subsection b. of this section</u></span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'>.</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.  The Department of Health,
in consultation with the Public Health Council, shall adopt rules and
regulations, pursuant to the &quot;Administrative Procedure Act,&quot;
P.L.1968, c.410 (C.52:14B-1 et seq.), as are necessary to effectuate the
purposes of this act.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    This act shall take
effect immediately. </p>

</div>

</body>

</html>
